Attenuation of novelty-induced hyperactivity of gria1-/- mice by cannabidiol and hippocampal inhibitory chemogenetics

Gene-targeted mice with deficient AMPA receptor GluA1 subunits (Gria1-/- mice) show robust hyperlocomotion in a novel environment, suggesting them to constitute a model for hyperactivity disorders such as mania, schizophrenia and attention deficit hyperactivity disorder. This behavioral alteration h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Aitta-aho, Teemu (VerfasserIn) , Sprengel, Rolf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 March 2019
In: Frontiers in pharmacology
Year: 2019, Jahrgang: 10
ISSN:1663-9812
DOI:10.3389/fphar.2019.00309
Online-Zugang:Verlag, Volltext: https://doi.org/10.3389/fphar.2019.00309
Verlag, Volltext: https://www.frontiersin.org/articles/10.3389/fphar.2019.00309/full
Volltext
Verfasserangaben:Teemu Aitta-aho, Milica Maksimovic, Kristiina Dahl, Rolf Sprengel and Esa R. Korpi

MARC

LEADER 00000caa a2200000 c 4500
001 1666084131
003 DE-627
005 20230427154332.0
007 cr uuu---uuuuu
008 190522s2019 xx |||||o 00| ||eng c
024 7 |a 10.3389/fphar.2019.00309  |2 doi 
035 |a (DE-627)1666084131 
035 |a (DE-599)KXP1666084131 
035 |a (OCoLC)1341225213 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Aitta-aho, Teemu  |e VerfasserIn  |0 (DE-588)1186813636  |0 (DE-627)1666084425  |4 aut 
245 1 0 |a Attenuation of novelty-induced hyperactivity of gria1-/- mice by cannabidiol and hippocampal inhibitory chemogenetics  |c Teemu Aitta-aho, Milica Maksimovic, Kristiina Dahl, Rolf Sprengel and Esa R. Korpi 
264 1 |c 29 March 2019 
300 |b Illustrationen 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.05.2019 
520 |a Gene-targeted mice with deficient AMPA receptor GluA1 subunits (Gria1-/- mice) show robust hyperlocomotion in a novel environment, suggesting them to constitute a model for hyperactivity disorders such as mania, schizophrenia and attention deficit hyperactivity disorder. This behavioral alteration has been associated with increased neuronal activation in the hippocampus, and it can be attenuated by chronic treatment with antimanic drugs, such as lithium, valproic acid and lamotrigine. Now we found that systemic cannabidiol strongly blunted the hyperactivity and the hippocampal c-Fos expression of the Gria1-/- mice, while not affecting the wildtype littermate controls. Acute bilateral intra-dorsal hippocampal infusion of cannabidiol partially blocked the hyperactivity of the Gria1-/- mice, but had no effect on wildtypes. The activation of the inhibitory DREADD receptor hM4Gi in the dorsal hippocampus by clozapine-N-oxide robustly inhibited the hyperactivity of the Gria1-/- mice, but had no effect on the locomotion of wildtype mice. Our results show that enhanced neuronal excitability in the hippocampus is associated with pronounced novelty-induced hyperactivity of GluA1 subunit-deficient mice. When this enhanced response of hippocampal neurons to novel stimuli is specifically reduced in the hippocampus by pharmacological treatment or by chemogenetic inhibition, Gria1-/- mice recover from behavioral hyperactivity, suggesting a hippocampal dysfunction in hyperactive behaviors that can be treated with cannabidiol. 
650 4 |a AMPA receptors 
650 4 |a c-fos 
650 4 |a Cannabidiol (CBD) 
650 4 |a DREADD receptors 
650 4 |a Hippocampus 
650 4 |a hM4Gi 
650 4 |a hyperactivity 
650 4 |a novelty 
700 1 |a Sprengel, Rolf  |d 1955-  |e VerfasserIn  |0 (DE-588)1060395665  |0 (DE-627)799661228  |0 (DE-576)163694230  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in pharmacology  |d Lausanne : Frontiers Media, 2010  |g Volume 10 (March 2019) Artikel-Nummer 309, Seite 1-11, 11 Seiten  |h Online-Ressource  |w (DE-627)642889392  |w (DE-600)2587355-6  |w (DE-576)335527108  |x 1663-9812  |7 nnas  |a Attenuation of novelty-induced hyperactivity of gria1-/- mice by cannabidiol and hippocampal inhibitory chemogenetics 
773 1 8 |g volume:10  |g year:2019  |g extent:11  |a Attenuation of novelty-induced hyperactivity of gria1-/- mice by cannabidiol and hippocampal inhibitory chemogenetics 
856 4 0 |u https://doi.org/10.3389/fphar.2019.00309  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fphar.2019.00309/full  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190522 
993 |a Article 
994 |a 2019 
998 |g 1060395665  |a Sprengel, Rolf  |m 1060395665:Sprengel, Rolf  |p 4 
999 |a KXP-PPN1666084131  |e 3478765056 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Attenuation of novelty-induced hyperactivity of gria1-/- mice by cannabidiol and hippocampal inhibitory chemogenetics","title_sort":"Attenuation of novelty-induced hyperactivity of gria1-/- mice by cannabidiol and hippocampal inhibitory chemogenetics"}],"person":[{"display":"Aitta-aho, Teemu","roleDisplay":"VerfasserIn","role":"aut","family":"Aitta-aho","given":"Teemu"},{"given":"Rolf","family":"Sprengel","role":"aut","display":"Sprengel, Rolf","roleDisplay":"VerfasserIn"}],"note":["Gesehen am 22.05.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1666084131","origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"29 March 2019"}],"id":{"eki":["1666084131"],"doi":["10.3389/fphar.2019.00309"]},"name":{"displayForm":["Teemu Aitta-aho, Milica Maksimovic, Kristiina Dahl, Rolf Sprengel and Esa R. Korpi"]},"physDesc":[{"noteIll":"Illustrationen","extent":"11 S."}],"relHost":[{"origin":[{"publisher":"Frontiers Media","dateIssuedKey":"2010","dateIssuedDisp":"2010-","publisherPlace":"Lausanne"}],"id":{"issn":["1663-9812"],"eki":["642889392"],"zdb":["2587355-6"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Frontiers in pharmacology","title":"Frontiers in pharmacology"}],"pubHistory":["2010 -"],"part":{"year":"2019","extent":"11","volume":"10","text":"Volume 10 (March 2019) Artikel-Nummer 309, Seite 1-11, 11 Seiten"},"disp":"Attenuation of novelty-induced hyperactivity of gria1-/- mice by cannabidiol and hippocampal inhibitory chemogeneticsFrontiers in pharmacology","note":["Gesehen am 08.09.20"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"642889392"}]} 
SRT |a AITTAAHOTEATTENUATIO2920